Rohan Palekar
Director · Neurogene Inc.
IndividualBuying only
- 2024
- Feb 24, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Rohan Palekar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christine Mikail Cvijic - $900K in NGNE purchases and sales in the last 12 months
- Stuart Cobb - $141K in NGNE purchases and sales in the last 12 months
- Rachel McMinn - $74K in NGNE purchases and sales in the last 12 months
- Julie Jordan - $18K in NGNE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Rohan Palekar?
Rohan Palekar is a corporate insider, tracked as Director of Neurogene Inc. (NGNE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Rohan Palekar last file a Form 4?
The most recent primary Form 4 on record is dated 24 February 2026, one of 5 filings going back to 2024.
Has Rohan Palekar been buying or selling stock?
Recorded transactions: 2 open-market purchases ($123K) and 0 open-market sales across all tracked filings.
